Vanda Pharmaceuticals announced its participation in four key healthcare investor conferences in September 2026, including events hosted by Wells Fargo, Cantor Global, H.C. Wainwright, and Morgan Stanley. The company will deliver corporate presentations at the Cantor Global and H.C. Wainwright conferences, which will be available live and archived on Vanda's website. This engagement highlights Vanda's efforts to update investors on its progress and strategic initiatives. Investors interested in the presentations are advised to register early and can access archived content for about 30 days after the events.
Baidu announced that its Class A ordinary shares listed on the Hong Kong Stock Exchange will be included in the Shanghai-Hong Kong Stock Connect program starting September 7, 2026. This inclusion allows eligible mainland Chinese investors to directly...
Curaleaf Holdings has opened a new cannabis dispensary in Riverview, Florida, marking its 77th location in the state and 178th across the U.S. This expansion reflects Curaleaf's strategy to grow its presence in Florida's fast-growing medical cannabis...
SpaceX's stock currently trades below its first closing price despite a strong IPO debut, with a consensus analyst target price about 48% higher than the current price. Raymond James analyst Brian Gesuale projects a much more optimistic outlook, sett...
Critical Metals has consolidated 92.5% ownership of the Tanbreez heavy rare earths project and secured a 15-year offtake agreement with REalloys. The company has started a 10,000-meter drilling program to better define its resources. Tanbreez stands ...
Xcel Energy declared a quarterly dividend of $0.5925 per share, continuing its streak of annual dividend increases aligned with its 4%-6% raise policy. The company operates as a regulated utility, providing predictable cash flows supported by state-a...
